Navigation Links
Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
Date:5/7/2009

(R) tablets; the possibility that the FDA will take enforcement action against us or one or more of our marketed drugs that do not have FDA-approved marketing applications; patient, physician and third-party payor acceptance of our products as safe and effective therapeutic products; our heavy dependence on the commercial success of a relatively small number of currently marketed products; our ability to obtain and maintain regulatory approvals to market and sell our products that do have FDA approved marketing applications; our ability to enter into additional strategic licensing, collaboration or co-promotion transactions on favorable terms, if at all; our ability to maintain compliance with Nasdaq listing requirements; adverse side effects experienced by patients taking our products; difficulties relating to clinical trials, including difficulties or delays in the completion of patient enrollment, data collection or data analysis; the results of preclinical studies and clinical trials with respect to our products under development and whether such results will be indicative of results obtained in later clinical trials; our ability to satisfy FDA and other regulatory requirements; our ability to obtain, maintain and enforce patent and other intellectual property protection for our products and product candidates; and the other factors described in Item 1A (Risk Factors) of our Annual Report on Form 10K, filed with the Securities and Exchange Commission (the SEC) on March 26, 2009, and other filings that we make with the SEC. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements.

In addition, the statements in this press release reflect our expectations and beliefs as of the date of this release. We anticipate that subsequent event
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Cornerstone Therapeutics to Host First Quarter 2009 Conference Call
2. OnCore(r) 9.0 Released: 'Top 5' Priorities and Collaborative Initiatives Cornerstones of Product Development
3. Cornerstone Therapeutics Announces New Board of Directors
4. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
5. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
6. Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25
7. Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
8. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
9. Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections
10. Prime Therapeutics Announces Departure of President and Chief Executive Officer Timothy Dickman
11. InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... 2015 , ... One can hardly argue against the fact that more and ... personal computers. These devices are being used as GPS, to make purchases, and yes, ... apps, STD positive singles can now join the prestigious social ranks of e-dating. ...
(Date:9/2/2015)... ... September 03, 2015 , ... ... determine who among America’s policymakers, public servants, activists, corporate executives, entrepreneurs, health care ... care. This year, that process led the magazine to tap the National League ...
(Date:9/2/2015)... ... September 02, 2015 , ... Chris Harrison of Harrison’s ... “It was a simple decision, really,” says Chris. “We have a lot of repeat ... the brands that work best for them—so we’ve given them the convenience of ordering ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, a leading ... two leaders who will deliver keynote presentations at the upcoming Digital Healthcare Innovation ... Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver the morning ...
(Date:9/2/2015)... CA (PRWEB) , ... September 02, 2015 , ... Based ... expand their fleet of truly superb luxury vehicles based on which of the latest ... to announce the latest step forward in pursuit of this goal: a 2015 ...
Breaking Medicine News(10 mins):Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3Health News:Harrison's Comfort Footwear Announces Expansion with New CHarrison Online Store 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2
... , ... ... ... ...
... ... ... ... ...
... be key, and an existing drug might help, scientists ... scientists say they,ve learned new details about molecular mechanisms ... lead to new treatments for alcoholism. , The University ... access to alcohol or sugar for nearly two months, ...
... seem to be making progress against these viruses, research ... of vaccination and prevention efforts may have the hepatitis ... from the U.S. Centers for Disease Control and Prevention. ... to various hepatitis strains. Antibodies are a kind of ...
... University have developed a new analytical method that opens ... information, with applications in fields as diverse as the ... we address here is this: When faced with a ... pieces of that information are relevant for solving a ...
... get life-threatening diseases under control, patients in the intensive ... same time. Even for experts, it is difficult to ... and interactions. The team headed by Dr. Thilo Bertsche, ... Heidelberg University Hospital, has now shown that physicians can ...
Cached Medicine News:Health News:The NASCAR Foundation Announces 'The Big Five' Projects for NASCAR Day 2Health News:The NASCAR Foundation Announces 'The Big Five' Projects for NASCAR Day 3Health News:The NASCAR Foundation Announces 'The Big Five' Projects for NASCAR Day 4Health News:Visionworks(R) Provides Eye Care For Pittsburgh's Smiling Irish Eyes 2Health News:Visionworks(R) Provides Eye Care For Pittsburgh's Smiling Irish Eyes 3Health News:Alcoholics' Relapses Better Understood 2Health News:Vaccination, Prevention Is Beating Back Hepatitis 2Health News:Research streamlines data processing to solve problems more efficiently 2Health News:Risk for patients in the intensive care unit clearly reduced 2
(Date:9/3/2015)... India , September 3, 2015 ... Metallic compounds, Organosulfurs, Organic acids, Phenolics, and Others) and ... & beverage, Paints & coatings, and Others) - Global ... and segments the Biocides Market with an analysis and ... as value. Browse   88 tables ...
(Date:9/2/2015)... Balloon angioplasty is a minimally invasive ... report is on global angioplasty balloons studies the ... report comprises an elaborate executive summary, which includes ... various segments and sub-segments included in the study. ... data analysis of the global angioplasty balloons market ...
(Date:9/2/2015)... , Sept. 2, 2015 About ... artificial implants used to replace, augment, or repair ... a wide range of applications including cosmetic, spinal, ... are made of different materials such as polymers, ... the global implantable medical devices market to grow ...
Breaking Medicine Technology:Biocides Market Worth 10.6 Billion USD by 2020 2Biocides Market Worth 10.6 Billion USD by 2020 3Biocides Market Worth 10.6 Billion USD by 2020 4Biocides Market Worth 10.6 Billion USD by 2020 5Angioplasty Balloons Market: : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Angioplasty Balloons Market: : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Global Implantable Medical Devices Market 2015-2019 2
... Corporation (NYSE: GPX ), announced today that ... with and into its wholly-owned subsidiary, General ... Physics, which is the sole operating subsidiary of GP ... be renamed GP Strategies Corporation when the merger becomes ...
... 15, 2011  MedAssurant, Inc., a leading provider ... Healthcare Partners, IPA (HCPIPA), one of the ... the Northeast, has selected MedAssurant,s Prospective Advantage® ... proactively identify gaps in care and quality ...
Cached Medicine Technology:GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation 2GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation 3Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 2Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 3
... is an economically priced 4-channel data ... research use in the fields of ... biology, zoology, biochemistry and biomedical engineering. ... signal conditioners and transducers. Two Pod ...
Near PT test card/Tumbling E, tumbling hands 5 1/2" X 8"....
Tumbling E/20' distance chart 22-1/2" X 11" 20/200 to 20/10....
... charts contain 5 pages of various contrast levels ... size is 9.5M. Contrast levels are 25%, 10%, ... be used at several different distances. These two ... offers a different set of symbols to ...
Medicine Products: